The United Laboratories International Holdings Limited (FRA:UNJ)

Market Cap	2.60B
Revenue (ttm)	1.68B
Net Income (ttm)	364.03M
Shares Out	n/a
EPS (ttm)	0.20
PE Ratio	7.15
Forward PE	7.77
Dividend	0.07 (5.17%)
Ex-Dividend Date	Sep 25, 2025

Volume	n/a
Average Volume	52
Open	1.280
Previous Close	1.270
Day's Range	1.280 - 1.290
52-Week Range	1.230 - 2.000
Beta	n/a
RSI	47.09
Earnings Date	Mar 26, 2026

About FRA:UNJ

The United Laboratories International Holdings Limited, an investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products. It operates through three segments: Bulk Medicine, Intermediate Products, and Finished Products. The company offers oral antibiotics, antimicrobials for injection, anti-cold products, cough medicines, ophthalmic drugs, antiviral drugs, anti-hepatitis B drugs, diabetes drugs, skin drugs for external use, cardiovascular and cerebrovascular drugs, amoxicillin...

• Industry: Pharmaceutical Preparations
• Founded: 1990
• Employees: 17,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: UNJ

Financial Performance

In 2024, FRA:UNJ's revenue was 13.76 billion, an increase of 0.14% compared to the previous year's 13.74 billion. Earnings were 2.66 billion, a decrease of -1.54%.

Financial numbers in CNY